Rapid Virological Response (RVR) of Daclatasvir and Sofosbuvir Plus Ribavirin in Non-Cirrhotic, Treatment-Naive Patients of Hepatitis C Virus Genotype 3

Background :To determine the efficacy of Daclatasvir and Sofosbuvir plus Ribavirin in achieving Rapid Virological Response (RVR) in patients of Hepatitis C genotype 3 who are non-cirrhotic and have not received any previous treatment. Methods: In this descriptive case series study, 100 non cirrhotic...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Muhammad Sarfraz, Arshad Rabbani, Muhammad Shahzad Manzoor, Zubair Ahmed, Ali Hassan
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Rawalpindi Medical University 2018-12-01
Serie:	Journal of Rawalpindi Medical College
Soggetti:	HCV Genotype 3 RVR Oral Direct Acting Antivirals DAA Daclatasvir
Accesso online:	https://www.journalrmc.com/index.php/JRMC/article/view/950
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!